Swiss pharma firm begins drafting proposals for 400,000 sq ft hub
Firm puts plans on ice after 2023 profits nearly halved
Swiss pharma giant to seek development partner for high-spec Reading facility
Swiss pharma firm looking at 10-year lease at the park’s first spec lab scheme